Stiolto Respimat (tiotropium bromide/olodaterol) is a prescription inhaler used to manage chronic obstructive pulmonary disease (COPD), including bronchitis and emphysema. It is not intended for asthma treatment. If you are on Medicare, you may be wondering about the cost of Stiolto Respimat and whether your plan covers it.

In this guide, we’ll break down the costs, Medicare coverage options, and ways to save money.

Medicare Coverage for Stiolto Respimat

Medicare provides prescription drug coverage through Medicare Part D and certain Medicare Advantage (Part C) plans. Here’s how these options can help cover the cost of Stiolto Respimat:

Medicare Part D

• Covers prescription drugs, including inhalers like Stiolto Respimat.
• Available as a stand-alone plan for those with Original Medicare (Part A and Part B).
• Requires a monthly premium, which varies by plan.
• Has an annual deductible (cannot exceed $590 in 2025).

Medicare Advantage (Part C)

• Many Medicare Advantage plans include prescription drug coverage.
• Costs and coverage vary by provider and location.
• May offer additional benefits, such as reduced copays.

Cost of Stiolto Respimat with Medicare

Out-of-Pocket Price Cap

As of June 1, 2024, pharmaceutical companies like Boehringer Ingelheim introduced an out-of-pocket price cap of $35 per month for their inhalers, including Stiolto Respimat.

*Costs may vary depending on your specific Medicare plan.

Additional Costs to Consider

Copayments and Coinsurance

• If your plan does not fully cover Stiolto Respimat, you may have a copayment (a fixed amount per prescription) or coinsurance (a percentage of the drug’s cost).
• For Medicare Part B, coinsurance is typically 20% after meeting your deductible.

Premiums

• Medicare Part D National Base Premium (2025): $36.78 per month.
• Higher-income beneficiaries may pay an Income-Related Monthly Adjustment Amount (IRMAA).

Ways to Save on Stiolto Respimat

If you find the cost of Stiolto Respimat too high, consider these options:

1. Medicare Extra Help Program

• Helps lower-income beneficiaries pay for prescription drugs.
• Can reduce or eliminate deductibles, premiums, and copays.

2. Manufacturer Discounts & Patient Assistance Programs

• Some pharmaceutical companies offer financial assistance for eligible patients.

3. State Pharmaceutical Assistance Programs (SPAPs)

• Certain states provide additional help for Medicare recipients who need expensive medications.

4. Generic or Alternative Medications

• Ask your doctor about alternatives that might be covered at a lower cost.

Key Takeaways

• Stiolto Respimat is covered by Medicare Part D and many Medicare Advantage plans.
• As of June 1, 2024, the out-of-pocket price for Stiolto Respimat is capped at $35 per month.
• Medicare Part D premiums start at $36.78 per month in 2025.
• Extra Help, manufacturer programs, and state assistance can further lower costs.

Conclusion

Managing COPD with Stiolto Respimat can be affordable with the right Medicare coverage. Be sure to compare plans, check for financial assistance options, and consult with your healthcare provider to find the best solution for your needs.

Have Questions?

If you need more details about Medicare coverage, consider speaking with a licensed Medicare specialist or visiting the official Medicare website for the most updated information.

Disclaimer: The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Minseos.com Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Minseos.com Media does not recommend or endorse any third parties that may transact the business of insurance.